Notice Number: NOT-AG-10-006
Release Date: June 22, 2010
National Institute on Aging (NIA), http://www.nia.nih.gov
The purpose of this notice is to announce that no revision and resubmission applications will be accepted for August 4, 2010 for the Alzheimer’s Disease Drug Development Program (U01) (PA-10-205). The first submission date for resubmission and revision applications will be November 5, 2010.
In addition, this notice clarifies Key Dates for this FOA.
The first letter of intent date will still be September 5, 2010 for new applications.
The first letter of intent date for resubmission or revision applications will be October 5, 2010.
The expiration date is still May 8, 2013.
All other aspects of the FOA remain unchanged.
For further information regarding this notice, please contact:
Suzana Petanceska, Ph.D.
Division of Neuroscience
National Institute on Aging
7201 Wisconsin Avenue, Suite 350, MSC 9205
Bethesda, MD 20892-9205
Telephone: (301) 496-9350
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)